earticle

영어

Aceclofenac, 2-[(2',6'-dichlorphenyl)amino]phenylacetoxiacetic acid, is a new nonsteroidal anti-inflammatory drug that belongs to the family of phenylacetic acids. It shows good tolerance and potent analgesic/antiinflammatory properties, and acts on cartilaginous chondriocytes, stimulating their repair mechanism. The purpose of the present study was to evaluate the bioequivalence of two aceclofenac products, tablet (Daewoong Pharmaceutical Co.) and capsule (Kyungdong Pharmaceutical Co.), according to the guideliner of Korea Food and Drug Administration (KFDA). The aceclofenac release from the two aceclofenac products in vitro was tested using KP VII Apparatus II method at pH 7.8 dissolution media. Sixteen normal male volunteers, years in age and kg in body weight, were divided into two groups and a randomized cross-over study was employed. After one tablet or capsule containing 100 mg of aceclofenac was orally administered, blood was taken at predetermined time intervals and the concentrations of aceclofenac in serum were determined using HPLC with UV detector. The dissolution profiles of the two aceclofenac products were very similar at pH 7.8 dissolution media. The pharmacokinetic parameters such as were calculated and ANOVA test was utilized for the statistical analysis of the parameters. The results showed that the differences in between two products were respectively, when calculated against the tablet. The powers , respectively. Minimum detectable differences were less than , ). The confidence intervals were within . Two parameters met the criteria of KFDA for bioequivalence, indicating that capsule is bioequivalent to tablet.